Literature DB >> 30371848

Rapid Separation and Quantitation of Cocaine and its Metabolites in Human Serum by Differential Mobility Spectrometry-tandem Mass Spectrometry (DMS-MS-MS).

Sara K Dempsey1, F Gerard Moeller2,3, Justin L Poklis1.   

Abstract

Cocaine continues to be one of the most widespread abused illicit drugs in the USA. Rapid methods are needed for the identification and quantitation of cocaine and its metabolites, benzoylecgonine (BE), ecgonine methyl ester (EME) and cocaethylene (CE), in biological specimens by clinical and forensic toxicology laboratories. Presented is a differential ion mobility spectrometry-tandem mass spectrometry (DMS-MS-MS) method for the analysis of cocaine and its major metabolites in human serum that requires minimal sample preparation and no column chromatography. A Shimadzu Nexera X2 ultra-high performance liquid chromatography system was used to infuse the samples into the DMS cell at a rate of 30 μL/min. Separation of cocaine and its metabolites were performed in a SelexION DMS component from Sciex coupled to a QTRAP 6500 with an IonDrive Turbo V source for TurbolonSpray® using acetonitrile as a chemical modifier. Analysis consisted of ramping the CoV from -35 V to -6 V while monitoring the multiple reaction monitoring (MRM) transitions of each analyte. The assay was evaluated for linearity, bias, precision, carryover, interferences and stability. Calibration curves ranged from 10 to 1,000 ng/mL with linear regression correlation coefficients (r2) of 0.9912 or greater for each analyte. The limit of quantitation was set at 10 ng/mL. Intra-day precision (%CV) ranged from 0% to 15% for cocaine, 1% to 19% for BE, 1% to 17% for EME and 0% to 18% for CE. Inter-day precision ranged from 9% to 14% for cocaine, 2% to 17% for BE, 5% to 11% for EME and 5% to 15% for CE. No carryover or interferences were detected. Bland-Altman analysis of previously analyzed specimens by UPLC-MS-MS showed variability of 30% or less. The method demonstrates the applicability of DMS-MS-MS for high throughout analysis of drugs and their metabolites in clinical and forensic toxicology laboratories.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30371848      PMCID: PMC6203121          DOI: 10.1093/jat/bky055

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  17 in total

1.  Rapid separation and characterization of cocaine and cocaine cutting agents by differential mobility spectrometry-mass spectrometry.

Authors:  Adam B Hall; Stephen L Coy; Erkinjon G Nazarov; Paul Vouros
Journal:  J Forensic Sci       Date:  2012-01-11       Impact factor: 1.832

2.  An automated SPE/LC/MS/MS method for the analysis of cocaine and metabolites in whole blood.

Authors:  Eshwar Jagerdeo; Madeline A Montgomery; Marc A Lebeau; Martin Sibum
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-07       Impact factor: 3.205

Review 3.  Differential mobility spectrometry/mass spectrometry history, theory, design optimization, simulations, and applications.

Authors:  Bradley B Schneider; Erkinjon G Nazarov; Frank Londry; Paul Vouros; Thomas R Covey
Journal:  Mass Spectrom Rev       Date:  2015-05-11       Impact factor: 10.946

4.  A quantitative LC-MS/MS method for simultaneous determination of cocaine and its metabolites in whole blood.

Authors:  Xiabin Chen; Xirong Zheng; Kai Ding; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  J Pharm Biomed Anal       Date:  2016-11-11       Impact factor: 3.935

5.  Analysis of cocaine, benzoylecgonine, ecogonine methyl ester, and ecgonine by high-pressure liquid chromatography-API mass spectrometry and application to a short-term degradation study of cocaine in plasma.

Authors:  A Klingmann; G Skopp; R Aderjan
Journal:  J Anal Toxicol       Date:  2001-09       Impact factor: 3.367

6.  A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma.

Authors:  S N Lin; D E Moody; G E Bigelow; R L Foltz
Journal:  J Anal Toxicol       Date:  2001-10       Impact factor: 3.367

7.  A validated stable isotope dilution liquid chromatography tandem mass spectrometry assay for the trace analysis of cocaine and its major metabolites in plasma.

Authors:  G Singh; V Arora; P T Fenn; B Mets; I A Blair
Journal:  Anal Chem       Date:  1999-05-15       Impact factor: 6.986

8.  Gas-phase separation of drugs and metabolites using modifier-assisted differential ion mobility spectrometry hyphenated to liquid extraction surface analysis and mass spectrometry.

Authors:  Tiffany Porta; Emmanuel Varesio; Gérard Hopfgartner
Journal:  Anal Chem       Date:  2013-12-02       Impact factor: 6.986

9.  Extending the dynamic range of the ion trap by differential mobility filtration.

Authors:  Adam B Hall; Stephen L Coy; Amol Kafle; James Glick; Erkinjon Nazarov; Paul Vouros
Journal:  J Am Soc Mass Spectrom       Date:  2013-09       Impact factor: 3.109

10.  Sensitive method for detection of cocaine and associated analytes by liquid chromatography-tandem mass spectrometry in urine.

Authors:  Loralie J Langman; Matthew W Bjergum; Christopher L Williamson; Frank W Crow
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

View more
  3 in total

1.  Development of a high-throughput differential mobility separation-tandem mass spectrometry (DMS-MS/MS) method for clinical urine drug testing.

Authors:  Shirin Hooshfar; Simone Tchu; Cassandra Yun; Kara L Lynch
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-01-03

2.  Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption.

Authors:  Roberto Mandrioli; Laura Mercolini; Michele Protti
Journal:  Molecules       Date:  2020-02-26       Impact factor: 4.411

3.  Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial.

Authors:  Sade E Johns; Lori Keyser-Marcus; Antonio Abbate; Edward Boone; Benjamin Van Tassell; Kathryn A Cunningham; Noelle C Anastasio; Justin L Poklis; Tatiana Ramey; F Gerard Moeller
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.